进行了实验室规模的实验，以研究24种内分泌干扰化合物（EDC）和药物活性化合物（PHAC）的可治疗性 在1和5 mg/L PAC下通过PAC+UF。实验是用天然有机物（NOM-）自由水和水进行的 Suwannee河NOM含量为2和5 mg/L（总有机碳）的水。用于通过超滤（UF）去除 单独使用膜时，NOM的存在会增加某些化合物和化合物的去除率 减少对其他人的搬迁。PAC+UF在统计学上具有显著性（a=0.05） 与UF单独使用相比，某些化合物的去除率有所提高，但这种增加是一种风险 PAC和NOM浓度的作用，并呈化合物依赖性。所有化合物 与对照组相比，在NOM存在的情况下，PAC+UF的去除率降低 在无NOM的水中，PAC+UF去除，表明NOM具有竞争性吸附。这个 在5 mg/L PAC和5 mg/L TOC条件下，PAC+UF的最小、中值和最大去除率为 分别为4%、55%和100%，表明PAC+UF对EDC和PHAC的去除 是变量和复合依赖的。包括18个参考文献，图。

Bench-scale experiments were carried out to investigate the treatability of 24 endocrine disrupting compounds (EDCs) and pharmaceutically active compounds (PhACs) by PAC+UF at 1 and 5 mg/L PAC. Experiments were conducted with natural organic matter- (NOM-)free water and with water containing Suwannee River NOM at 2 and 5 mg/L (as TOC). For removal by the ultrafiltration (UF) membrane alone, the presence of NOM caused an increase in removal for some compounds and a reduction in removal for others. PAC+UF provided a statistically significant (a = 0.05) improvement in removal compared to UF alone for some compounds, but this increase was a function of PAC and NOM concentration, and was compound-dependent. All compounds experienced a reduction in removal by PAC+UF in the presence of NOM when compared to removal by PAC+UF in NOM-free water, which indicates competitive adsorption by NOM. The minimum, median, and maximum removal by PAC+UF at 5 mg/L PAC and 5 mg/L TOC was 4%, 55%, and 100%, respectively, indicating that the removal of EDCs and PhACs by PAC+UF is variable and compound-dependent. Includes 18 references, figure.